reports
MYM Obtains Final Order for Arrangement with IM Cannabis Corp.
MYM Obtains Final Order for Arrangement with IM Cannabis Corp. VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”), is pleased to announce that it has been granted the final court order from the Supreme Court of British Columbia approving the plan of arrangement (the “Arrangement”) with IM Cannabis Corp. (“IMC”), pursuant to which, among other things, IMC, through its wholly-owned subsidiary Trichome Financial Corp., will acquire all of the issued and outstanding common shares of MYM (the “MYM Shares”) ...
MYM Shareholders Approve Plan of Arrangement with IM Cannabis
MYM Shareholders Approve Plan of Arrangement with IM Cannabis VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”), is pleased to announce that, at its special meeting (the “MYM Meeting”) of shareholders of MYM (“MYM Shareholders”), MYM Shareholders approved the plan of arrangement (the “Arrangement”) with IM Cannabis Corp. (“IMC”) originally announced April 1, 2021, pursuant to which, among other things, IMC will acquire all of the issued and outstanding common shares of MYM (“MYM Shares”) for considera...
MYM’s Acquisition by IMCC Receives Positive Recommendations from leadi...
MYM’s Acquisition by IMCC Receives Positive Recommendations from leading Independent Proxy Advisory Firms Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favour of the Transaction VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”) is pleased to announce that both Glass, Lewis & Co. (“Glass Lewis”) and Institutional Shareholder Services Inc. (“ISS”), the two leading inde...
MYM Provides Timeline for Special Meeting of Shareholders and Announce...
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") published a notice of meeting and record date for the upcoming special meeting of shareholders of MYM (the "Meeting") disclosing that the record date will be May 31, 2021 and the Meeting will be on July 5, 2021. At the Meeting, shareholders will be asked to consider and vote on a special resolution approving, among other things, the arrangement agreement entered into on March 31, 2021 between MYM, IM Cannabis Corp., and Trichome Financial Corp. (the "Arrang...
MYM Releases Q3 2021 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") today announced its financial results for the three-month period ending February 28, 2021 ("Q3 2021"). The Company's Financial Statements and Management Discussion & Analysis ("MD&A") are available on . Key Highlights for Q3 2021Gross revenue of $4.4 million, an increase of 8% from the prior quarterPositive EBITDA of $212,628Expanded distribution to three new markets: Yukon, Nunavut, and OntarioSubsequent to Q3 2021, announced a definitive agreement to m...
MYM Continues to Secure Additional Support for Merger with IMCC
Total voting support agreements for the Transaction now represent 44.4%, or 162.7 million, of the total votes outstanding including all senior management and board membersShareholders to benefit from a global platform of premium and super premium brands and distribution through Canada, Israel and EuropeThe Transaction has been approved by an MYM Special Committee of Independent Directors Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company"), is pleased to announce that it has received additional voting suppor...
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Su...
Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMCHighland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1]Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergiesMYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on respective closing prices on March 31, 2021Super premium positioning, complementary brands, enhanced distribution and export opportunities to Isra...
MYM Nutraceuticals Inc.: Highland Grow Expands Distribution into Nunav...
Vancouver, British Columbia--(Newsfile Corp. - March 5, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") is pleased to announce its wholly owned subsidiary and Health Canada licensed cannabis producer, Highland Grow Inc., ("Highland Grow"), has received authorization from the Government of Nunavut to supply Highland Grow cannabis products throughout Nunavut."We are thrilled at the opportunity to work with the Government of Nunavut and share Highland Grow and Coastal Connection branded cannabis products for the benefit of Nunavut and its people," said Michael ...
MYM Nutraceuticals Inc: Highland Grow Expands Distribution into Ontari...
Vancouver, British Columbia--(Newsfile Corp. - February 4, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") is pleased to announce its wholly owned subsidiary and Health Canada licensed cannabis producer, Highland Grow Inc., ("Highland Grow"), has entered into a supply agreement with the Ontario Cannabis Store ("OCS") to supply Highland Grow branded cannabis products throughout the province of Ontario.Under the terms of the agreement, Highland Grow will initially offer two cultivars, "White Lightning" and "Gaelic Fire", both in 3.5g formats."Entering the Onta...
1 director sold
A director at MYM Nutraceuticals Inc sold 1,471,233 shares at 0.000CAD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
MYM Nutraceuticals, New Manufacturing Facility for Cannabis Consumable...
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2018) - Rob Gietl, CEO of MYM Nutraceuticals explains how their cannabis company aims to focus on the medical industry.If you cannot view the video above, please visit:MYM Nutraceuticals is being featured on BNN Bloomberg on Nov. 3 - Nov. 4, 2018 Monday through Friday, throughout the day and evenings.MYM Nutraceuticals (CSE: MYM)About CEO Clips:CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites includ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.